Drug Profile
Pantethine
Alternative Names: OC-2Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Oculon
- Class Antihyperlipidaemics; Small molecules; Vitamins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cataracts
Most Recent Events
- 16 May 2006 Discontinued - Phase-III for Cataracts in USA (Ophthalmic)
- 20 Feb 1997 Phase-III clinical trials for Cataracts in USA (Ophthalmic)